Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis

Isfahan University of Medical Sciences48 enrolled

Overview

Plantar fasciitis is one of the most common causes of heel pain. This study will be performed in the purpose of determination the effects of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis

Plantar fasciitis is the most common cause of inferior heel pain, A great variety of therapies have been reported for the treatment of plantar fasciitis including extracorporeal shock wave therapy. Gastrosoleus muscle dysfunction is one of the most common contributing factors to this disease .Despite the long history and the fact that this is a common diagnosis made in clinical practice, the exact cause and best treatment for this condition still are being explored. Although there is lack of high-quality studies demonstrating the efficacy of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis , this study will be performed to examine the effect of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Plantar Fasciitis

Interventions

Extracorporeal shock wave therapy 1PROCEDURE

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region and (400 shock waves/session of 0.2 mJ/mm2 per each trigger point) for gastrosoleus trigger points , 3 sessions at weekly intervals

Extracorporeal shock wave therapy 2PROCEDURE

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region , 3 sessions at weekly intervals

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. clinical diagnosis of plantar fasciitis 2. having at least one Gastrosoleus trigger point concomitantly. 3. having no response to conservative treatments for at least 3 months 4. willingness to participate Exclusion Criteria: 1. Dysfunction of the knee or ankle 2. Neurologic abnormalities 3. Bleeding tendency (hereditary or acquired) 4. Nerve entrapment syndrome 5. A previous operation on the heel 6. Pregnancy 7. Evidences of Infection in lower limbs 8. A medical History of tumor 9. previous local corticosteroid injection within 12 weeks

Locations (1)

Department of Rehabilitation, Alzahra Hospital

Isfahan, Isfahan, Iran

Outcomes

Primary Outcomes

Change from baseline in pain severity after 3 weeks

The pain score (100 mm Visual Analogue Score ) is evaluated before the first session and 4 weeks after the last session.

Time frame: Up to 4 weeks

Secondary Outcomes

Change from baseline in pain degree after 2 months.

The pain score (100 mm Visual Analogue Score ) and the modified criteria of the Roles and Maudsley score are evaluated at baseline and then 2 months after therapy.

Time frame: Up to 2 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.